Louisiana, Alabama, and Arkansas attorneys general hauled blue-state shield laws before the Supreme Court, arguing the statutes protect illegal abortion-pill shipments into states that ban them.
Louisiana Attorney General Liz Murrill, joined by Alabama Attorney General Steve Marshall and Arkansas Attorney General Tim Griffin, filed the case against New York, California, and Massachusetts. They contend those states’ shield laws block cooperation with probes into providers who mail abortion drugs into states that restrict them.
Fox News reported the same attorneys general also filed a separate roughly 100-page lawsuit in Louisiana against more than 30 people and organizations accused of advertising, prescribing, dispensing, or shipping the pills into their states.
Murrill put the charge in plain terms.
She told reporters, “This is drug dealing and it’s illegal,” and added, “And we’re going to continue to do everything that we can to enforce the laws in our states.”
The Supreme Court complaint targets statutes Murrill called “very comprehensive.” Louisiana has already indicted New York physician Margaret Carpenter and California physician Remy Coeytaux over allegations they prescribed abortion drugs sent into Louisiana. Extradition efforts failed.
New York Gov. Kathy Hochul refused to hand over Carpenter. California Gov. Gavin Newsom rejected Louisiana’s request for Coeytaux in January. The high-court filing cited Hochul’s remark that there was “no way in h***” she would comply with the extradition request. New York later strengthened its shield law, including by allowing abortion-drug prescribers to keep their names off prescription labels.
Newsom’s earlier response on X left little doubt about the posture of blue-state leadership. When Murrill vowed action, he wrote: “Go f--- yourself. California will never help you criminalize healthcare.”
Murrill drew a direct comparison on enforcement. “I think that if I sent guns into their states illegally, they would certainly try to come after me,” she said. “I said specifically at the time that we would be coming for them and we are.” She added, “We are going to take down those laws using every tool that we have at our disposal.”
The Supreme Court remains a central battleground for contested enforcement power, including fights over how far federal and state authorities can go when deportation policy collides with lower-court limits.
The Louisiana complaint alleges providers used online questionnaires to collect customer information, then mailed abortion drugs into states where distribution is prohibited. Investigators conducted controlled purchases. Murrill said the pills arrived in small bags, sometimes in quantities that exceeded ordinary prescriptions.
“We’ve seen it for ourselves,” she said. “There’s no supervision, there’s no healthcare, there’s no communication whatsoever. It’s all done online.”
The filing also alleges some organizations openly acknowledged that their conduct violated the plaintiff states’ laws while relying on shield laws to avoid legal consequences. That is the core of the red-state case: open interstate distribution paired with legal walls against investigation.
Murrill described one local case her office documented. “We have a situation in one town in Louisiana that we’ve documented and investigated where a father did not want his teenage daughter to keep a pregnancy,” she said. “And so he basically put the medication in a smoothie, forced her to drink it. She did ultimately give birth to that baby at 23 weeks and is still in a NICU fighting for its life.”
That account, if sustained in court, shows why state officials treat unsupervised mail-order pills as more than a policy disagreement. It is a public-safety and parental-control problem landing on local hospitals and families.
Hochul framed the shield laws as protection. “No one should have to fear being punished for seeking or providing reproductive care,” she said. “As anti-abortion extremists in other states try to reach across our borders and threaten patients and providers, New York will stand up for them. Our shield laws are there to protect that freedom.” She has also cast New York as a “safe haven for reproductive rights.”
Murrill’s side rejects that framing. After the 2022 Dobbs decision returned abortion policy to the states, Louisiana, Alabama, and Arkansas chose tight limits. Blue-state shield laws, they argue, let out-of-state actors nullify those choices by mail and then refuse basic law-enforcement cooperation.
Susan B. Anthony Pro-Life America President Marjorie Dannenfelser backed the litigation and accused Democratic-led states of using the laws “to obstruct justice.”
"Democrats’ pro-abortion extremism has brought this country to a crisis point. Abortion activists flagrantly sell dangerous drugs across state lines and women and children pay the price, with more and more survivors of ‘death in a pill’ bravely coming forward,"
The clash sits alongside other high-court fights over state authority and federal power, from redistricting disputes to emergency appeals on immigration enforcement.
Murrill said federal regulators have not done enough. “Obviously we think the FDA could be doing more and we’ve asked them to do that.” Louisiana has separately challenged federal rules that eliminated an in-person dispensing requirement for mifepristone, the primary abortion pill.
That FDA fight has already reached the justices. The Washington Examiner reported that Justice Samuel Alito extended a temporary pause on a 5th Circuit ruling that had blocked nationwide online sales of mifepristone, preserving mail access while Louisiana’s suit against the agency proceeds. The 5th Circuit found Louisiana was “suffering irreparable harm” because online pills effectively nullify state law prohibiting elective abortion. Drug makers warned the appeals-court order would inject “immediate confusion and upheaval into highly time-sensitive medical decisions.”
In short, red states are pressing on two tracks: civil and criminal pressure on the alleged shipping networks, and a direct attack on the federal rules that made remote prescribing and mail delivery routine. Dannenfelser urged the Justice Department to settle Louisiana’s FDA litigation. Fox News Digital sought comment from the New York, California, and Massachusetts governors’ offices.
Other recent Supreme Court dockets show the same pattern of rapid emergency litigation when enforcement collides with lower-court orders, including the Trump administration’s push to restore third-country deportations after an appeals-court setback.
Dobbs struck down Roe v. Wade and gave elected officials the power to set abortion policy in their states. Louisiana, Alabama, and Arkansas used that power. New York, California, and Massachusetts answered with shield laws that, according to the red-state filings, bar officials from assisting other states seeking to enforce judgments tied to abortion-related conduct.
Murrill’s dual filings force the question into the open. Can a state ban or tightly restrict abortion drugs inside its borders if neighboring states protect the people mailing those drugs in, refuse extradition, and hide prescriber names on labels? The plaintiff attorneys general say the answer has to be no, or Dobbs becomes a paper promise.
The Supreme Court will decide whether those shield statutes can stand as a wall against ordinary interstate law enforcement. Parallel fights over detention and removal authority continue to reach the justices as well, including fresh petitions to revive immigration detention rules after lower-court losses.
Missouri’s map fights have likewise kept the high court in the middle of raw state-power contests, with redistricting chaos returning on a tight clock.
When states ban a drug and other states build legal fortresses around the people shipping it in, voters are not watching a culture debate. They are watching whether state law still binds anyone beyond the state line.